Processa (PCSA) Director Baluch Khoso Buys 2,269 Shares

What Happened
Director Baluch Khoso acquired 2,269 shares of Processa Pharmaceuticals (PCSA) on 2026-03-31 at $2.54 per share, for a total transaction value of approximately $5,752. This was a purchase (transaction code P), which is a direct buy of company stock rather than a sale or option exercise; motivations are not disclosed.

Key Details

• Transaction date: 2026-03-31
• Price per share: $2.54
• Shares acquired: 2,269 — total value ≈ $5,752
• Transaction type/method: Purchase (open market or private purchase indicated) — code P
• Filing date: 2026-04-01 (filed the next day; appears timely under the SEC’s 2-business-day reporting window)
• Shares owned after transaction: Not specified in the information provided — see the full Form 4 for post-transaction holdings and any footnotes
• Footnotes/plan info: None reported in the provided summary

Context
This is a relatively small-dollar insider purchase by a company director; purchases can be a useful data point for investors but do not by themselves indicate future performance. Retail investors should consult the full Form 4 (Accession No. 0000897069-26-000741) for complete ownership details and any additional disclosures (e.g., 10b5-1 plans).